2016 Hematological Malignancies

First page Previous page 55 Next page Last page

Efficacy and Tolerability of ABVD HL patients >60y (E2496; n=45)

5-year FFS 53% Bleomycin lung toxicity in 24% (18% died)

Log-rank two sided P = 0.99

Made with